Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Convergence Insufficiency: early-phase trial registry
4 of 7 indexed Convergence Insufficiency trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Convergence Insufficiency: 7 US clinical trials tracked, 4 recruiting.
Convergence Insufficiency is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is New Jersey Institute of Technology, running 2 of these trials.
Enrollment posture brief
Registry condition convergence-insufficiency
OPEN 4 | RECR 57% | LATE 0 | EARLY 2 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)
Convergence Insufficiency lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Convergence Insufficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Convergence Insufficiency is recruiting above its size-band peers.
4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Convergence Insufficiency research.
New Jersey Institute of Technology accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Convergence Insufficiency enrolment sits around 100 participants.
Median target enrolment is 100 among the 7 trials that report a genuine target (sentinel values excluded). 3 of those (42.9%) plan for fewer than 100 participants.
-
Convergence Insufficiency research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency
Midwestern University
NCT05877560
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
New Jersey Institute of Technology
NCT06105892
Effectiveness of Virtual Reality Vision Therapy - VERVE
OculoMotor Technologies
NCT04691427
Home-based Vision Therapy
VA Office of Research and Development
NCT06886737
A Prospective Observational Study of Adult Strabismus
Jaeb Center for Health Research
NCT02510040
Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency
New Jersey Institute of Technology
NCT03593031
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
Hennepin Healthcare Research Institute
NCT03319966
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Convergence Insufficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Convergence Insufficiency trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Convergence Insufficiency page
7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Convergence Insufficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- New Jersey Institute of Technology sponsors the most Convergence Insufficiency trials on record, review their full trial history before evaluating a specific study. See New Jersey Institute of Technology's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Convergence Insufficiency condition card totals 7 registered trials; most-linked intervention Botox Injection; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.